The WACBD is staffed by several internationally recognized researchers and conducts numerous clinical and translational studies. Many of these studies are enabled, enhanced and safeguarded by a strong collaborative relationship with the Research Institute at Bloodworks Northwest.
Community Counts is a public health monitoring program funded by CDC’s Division of Blood Disorders. The purpose of this project is to gather and share information about common health issues, medical complications, and causes of death that affect people with bleeding disorders cared for in U.S. Hemophilia Treatment Centers (HTCs).
Some other clinical studies WACBD is conducting include:
Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A
Other clinical trials investigating gene therapy and other treatments for bleeding disorders are ongoing. Make sure you ask us during your visit about potential studies you might be eligible for when you come and visit us.